310 related articles for article (PubMed ID: 37231524)
1. Abnormal glycosylation in glioma: related changes in biology, biomarkers and targeted therapy.
Yue J; Huang R; Lan Z; Xiao B; Luo Z
Biomark Res; 2023 May; 11(1):54. PubMed ID: 37231524
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis Identified Glycosyltransferase Signature to Predict Glioma Prognosis and TAM Phenotype.
Qi Y; Lv W; Liu X; Wang Q; Xing B; Jiang Q; Wang Z; Huang Y; Shu K; Lei T
Biomed Res Int; 2023; 2023():6082635. PubMed ID: 36685667
[TBL] [Abstract][Full Text] [Related]
3. Biological implications and clinical potential of invasion and migration related miRNAs in glioma.
Guo X; Jiao H; Cao L; Meng F
Front Integr Neurosci; 2022; 16():989029. PubMed ID: 36479040
[TBL] [Abstract][Full Text] [Related]
4. Clinical Value of TXNDC12 Combined With IDH and 1p19q as Biomarkers for Prognosis of Glioma.
Wang X; Yang Q; Liu N; Bian Q; Gao M; Hou X
Pathol Oncol Res; 2021; 27():1609825. PubMed ID: 34629960
[No Abstract] [Full Text] [Related]
5. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
6. Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas.
Viapiano MS; Bi WL; Piepmeier J; Hockfield S; Matthews RT
Cancer Res; 2005 Aug; 65(15):6726-33. PubMed ID: 16061654
[TBL] [Abstract][Full Text] [Related]
7. Circadian Clock Genes Act as Diagnostic and Prognostic Biomarkers of Glioma: Clinic Implications for Chronotherapy.
Chai R; Liao M; Ou L; Tang Q; Liang Y; Li N; Huang W; Wang X; Zheng K; Wang S
Biomed Res Int; 2022; 2022():9774879. PubMed ID: 35832846
[TBL] [Abstract][Full Text] [Related]
8. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
9. Glycosylation modification identifies novel molecular phenotypes and prognostic stratifications of glioma.
Wang C; Xiong K
Gene; 2022 Aug; 836():146677. PubMed ID: 35714799
[TBL] [Abstract][Full Text] [Related]
10. Glycosylation in Renal Cell Carcinoma: Mechanisms and Clinical Implications.
Zhu X; Al-Danakh A; Zhang L; Sun X; Jian Y; Wu H; Feng D; Wang S; Yang D
Cells; 2022 Aug; 11(16):. PubMed ID: 36010674
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis of LMAN1 expression, clinical characteristics, and its effects on cell proliferation and invasion in glioma.
Du Q; Lin Y; Zhang W; He F; Xu Y; Chen Z
Brain Res; 2022 Aug; 1789():147952. PubMed ID: 35623391
[TBL] [Abstract][Full Text] [Related]
12. Long Non-Coding RNAs in Gliomas: From Molecular Pathology to Diagnostic Biomarkers and Therapeutic Targets.
Vecera M; Sana J; Lipina R; Smrcka M; Slaby O
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30217088
[TBL] [Abstract][Full Text] [Related]
13. Rediscovering Potential Molecular Targets for Glioma Therapy Through the Analysis of the Cell of Origin, Microenvironment and Metabolism.
Guo X; Wang T; Huang G; Li R; Da Costa C; Li H; Lv S; Li N
Curr Cancer Drug Targets; 2021; 21(7):558-574. PubMed ID: 33949933
[TBL] [Abstract][Full Text] [Related]
14. The Role of BEHAB/Brevican in the Tumor Microenvironment: Mediating Glioma Cell Invasion and Motility.
Giamanco KA; Matthews RT
Adv Exp Med Biol; 2020; 1272():117-132. PubMed ID: 32845505
[TBL] [Abstract][Full Text] [Related]
15. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
Di K; Linskey ME; Bota DA
Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
[TBL] [Abstract][Full Text] [Related]
16. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma.
Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q
Front Immunol; 2022; 13():1011757. PubMed ID: 36325335
[TBL] [Abstract][Full Text] [Related]
17. Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification.
Peng Z; Wang J; Tong S; Wu Y; Yi D; Xiang W
Front Immunol; 2023; 14():1128151. PubMed ID: 37006287
[TBL] [Abstract][Full Text] [Related]
18. Identification of thioredoxin domain containing family members' expression pattern and prognostic value in diffuse gliomas via in silico analysis.
Kocatürk B
Cancer Med; 2023 Feb; 12(3):3830-3844. PubMed ID: 36106447
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-144 represses gliomas progression and elevates susceptibility to Temozolomide by targeting CAV2 and FGF7.
Liu ZQ; Ren JJ; Zhao JL; Zang J; Long QF; Du JJ; Jia XT; Gu NB; Di ZL; Qian YH; Li SZ
Sci Rep; 2020 Mar; 10(1):4155. PubMed ID: 32139705
[TBL] [Abstract][Full Text] [Related]
20. Identification of PIEZO1 as a potential prognostic marker in gliomas.
Zhou W; Liu X; van Wijnbergen JWM; Yuan L; Liu Y; Zhang C; Jia W
Sci Rep; 2020 Sep; 10(1):16121. PubMed ID: 32999349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
